Blog
Pfizer signs deal allowing generics to produce COVID pill

Pfizer signs deal allowing generics to produce COVID pill

On the 16th of November, Pfizer announced a deal with international public health group Medicines Patent Pool (MPP) that will allow generic drug manufacturers to produce and supply its experimental antiviral COVID-19 pill. The licensing agreement will authorise the MPP to grant sub-licenses to qualified drug companies in 95 low and middle-income countries, giving residents access to affordable life-saving treatment.  More…

Brazilian
Blog
Brazilian pharmaceutical patents
no longer subject to ANVISA’s
prior approval

Brazilian pharmaceutical patents no longer subject to ANVISA’s prior approval

Back in March this year, the Brazilian Federal Government issued the Provisional Measure No. 1,040/2021. Their aim is to improve the business environment in Brazil and elevate the country’s position in the World Bank’s “Doing Business” ranking. President Bolsonaro has now sanctioned this measure and the corresponding Law No 14.195 entered into force on August 26th, 2021. More…